Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Análise do Perfil Epidemiológico de Hanseníase no Brasil no período de 2010 a 2019/ Analysis of the Epidemiological Profile of Leprosy in Brazil in the period from 2010 to 2019

Bernardes MP, Oliveira GSD, Grattapaglia RPA, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2021; 4 (6) : 23692-23699.
Download PDF
Publication

Exploring host and pathogen biomarkers for leprosy

Tió-Coma M. Leiden University. 2021;
Download PDF
Publication

Treatment and Evaluation Advances in Leprosy Neuropathy.

Ebenezer G, Scollard D. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2021;
Download PDF
Publication

Lucius phenomenon: the importance of a primary dermatological care.

Pinheiro JV, Pontes MADA, Neto J, et al. Anais brasileiros de dermatologia. 2021;
Download PDF
Publication

Presenting symptoms of leprosy at diagnosis: Clinical evidence from a cross-sectional, population-based study.

Chen X, Zha S, Shui T. PLoS neglected tropical diseases. 2021; 15 (11) : e0009913.
Download PDF
Publication

Low risk of relapse and deformity among leprosy patients who completed multi-drug therapy regimen from 2005 to 2010: A cohort study from four districts in South India.

Rajkumar P, Purushothaman G, Ponnaiah M, et al. PLoS neglected tropical diseases. 2021; 15 (11) : e0009950.
Download PDF
Publication

[Combined use of serologic markers and spatial analysis for epidemiological surveillance of leprosy Uso conjunto de los marcadores serológicos y del análisis espacial en la vigilancia epidemiológica de la lepra].

Ribeiro G, Barreto J, Bueno IDC, et al. Revista panamericana de salud publica = Pan American journal of public health. 2021;
Download PDF
Publication

RLEP LAMP for the laboratory confirmation of leprosy: towards a point-of-care test.

Saar M, Beissner M, Gültekin F, et al. BMC infectious diseases. 2021; 21 (1) : 1186.
Download PDF
Publication

Acid-Fast Bacilli Positivity Rate and Associated Factors among Leprosy Suspected Cases attending Selected Health Facilities located in West Arsi Zone, Oromia, Ethiopia.

Bekala D, Reda DY, Ali M. Infection and drug resistance. 2021;
Download PDF
Publication

Altered cytokine profiles in relapsed paucibacillary leprosy: a case report.

Sameshima T, Maeda Y, Mukai T, et al. BMC infectious diseases. 2021; 21 (1) : 1155.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 235
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD